Novel Grb14-Mediated Cross Talk between Insulin and p62/Nrf2 Pathways Regulates Liver Lipogenesis and Selective Insulin Resistance

REFERENCES

• Brown MS, Goldstein JL. 2008. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 7:95–96. http://dx.doi.org/10.1016/j.cmet.2007.12.009.
   PubMed Web of Science ®Google Scholar
• Taniguchi CM, Emanuelli B, Kahn CR. 2006. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7:85–96.
   PubMed Web of Science ®Google Scholar
• Smith BW, Adams LA. 2011. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat Rev Endocrinol 7:456–465. http://dx.doi.org/10.1038/nrendo.2011.72.
   PubMed Web of Science ®Google Scholar
• Jeon TI, Osborne TF. 2012. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab 23:65–72. http://dx.doi.org/10.1016/j.tem.2011.10.004.
   PubMed Web of Science ®Google Scholar
• Kasus-Jacobi A, Perdereau D, Auzan C, Clauser E, Van Obberghen E, Mauvais-Jarvis F, Girard J, Burnol A-F. 1998. Identification of the rat adapter Grb14 as an inhibitor of insulin actions. J Biol Chem 273:26026–26035. http://dx.doi.org/10.1074/jbc.273.40.26026.
   PubMed Web of Science ®Google Scholar
• Kooner JS, Saleheen D, Sim X, Sehmi J, Zhang W, Frossard P, Been LF, Chia KS, Dimas AS, Hassanali N, Jafar T, Jowett JB, Li X, Radha V, Rees SD, Takeuchi F, Young R, Aung T, Basit A, Chidambaram M, Das D, Grundberg E, Hedman AK, Hydrie ZI, Islam M, Khor CC, Kowlessur S, Kristensen MM, Liju S, Lim WY, Matthews DR, Liu J, Morris AP, Nica AC, Pinidiyapathirage JM, Prokopenko I, Rasheed A, Samuel M, Shah N, Shera AS, Small KS, Suo C, Wickremasinghe AR, Wong TY, Yang M, Zhang F, Abecasis GR, Barnett AH, Caulfield M, Deloukas P, Frayling TM, Froguel P, Kato N, Katulanda P, Kelly MA, Liang J, Mohan V, Sanghera DK, Scott J, Seielstad M, Zimmet PZ, Elliott P, Teo YY, McCarthy MI, Danesh J, Tai ES, Chambers JC. 2011. Genome-wide association study in individuals of South Asian ancestry identifies six new type 2 diabetes susceptibility loci. Nat Genet 43:984–989. http://dx.doi.org/10.1038/ng.921.
   PubMed Web of Science ®Google Scholar
• Manning AK, Hivert MF, Scott RA, Grimsby JL, Bouatia-Naji N, Chen H, Rybin D, Liu CT, Bielak LF, Prokopenko I, Amin N, Barnes D, Cadby G, Hottenga JJ, Ingelsson E, Jackson AU, Johnson T, Kanoni S, Ladenvall C, Lagou V, Lahti J, Lecoeur C, Liu Y, Martinez-Larrad MT, Montasser ME, Navarro P, Perry JR, Rasmussen-Torvik LJ, Salo P, Sattar N, Shungin D, Strawbridge RJ, Tanaka T, van Duijn CM, An P, de Andrade M, Andrews JS, Aspelund T, Atalay M, Aulchenko Y, Balkau B, Bandinelli S, Beckmann JS, Beilby JP, Bellis C, Bergman RN, Blangero J, Boban M, Boehnke M, Boerwinkle E, et al.. 2012. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 44:659–669. http://dx.doi.org/10.1038/ng.2274.
   PubMed Web of Science ®Google Scholar
• Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Steinthorsdottir V, Strawbridge RJ, Khan H, Grallert H, Mahajan A, Prokopenko I, Kang HM, Dina C, Esko T, Fraser RM, Kanoni S, Kumar A, Lagou V, Langenberg C, Luan J, Lindgren CM, Muller-Nurasyid M, Pechlivanis S, Rayner NW, Scott LJ, Wiltshire S, Yengo L, Kinnunen L, Rossin EJ, Raychaudhuri S, Johnson AD, Dimas AS, Loos RJ, Vedantam S, Chen H, Florez JC, Fox C, Liu CT, Rybin D, Couper DJ, Kao WH, Li M, Cornelis MC, Kraft P, Sun Q, van Dam RM, Stringham HM, Chines PS, Fischer K, Fontanillas P, et al.. 2012. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44:981–990. http://dx.doi.org/10.1038/ng.2383.
   PubMed Web of Science ®Google Scholar
• Cariou B, Capitaine N, Le Marcis V, Vega N, Bereziat V, Kergoat M, Laville M, Girard J, Vidal H, Burnol AF. 2004. Increased adipose tissue expression of Grb14 in several models of insulin resistance. FASEB J 18:965–967.
   PubMed Web of Science ®Google Scholar
• Park JJ, Berggren JR, Hulver MW, Houmard JA, Hoffman EP. 2006. GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. Physiol Genomics 27:114–121. http://dx.doi.org/10.1152/physiolgenomics.00045.2006.
   PubMed Web of Science ®Google Scholar
• Bereziat V, Kasus-Jacobi A, Perdereau D, Cariou B, Girard J, Burnol A-F. 2002. Inhibition of insulin receptor catalytic activity by the molecular adapter Grb14. J Biol Chem 277:4845–4852. http://dx.doi.org/10.1074/jbc.M106574200.
   PubMed Web of Science ®Google Scholar
• Desbuquois B, Bereziat V, Authier F, Girard J, Burnol AF. 2008. Compartmentalization and in vivo insulin-induced translocation of the insulin-signaling inhibitor Grb14 in rat liver. FEBS J 275:4363–4377. http://dx.doi.org/10.1111/j.1742-4658.2008.06583.x.
   PubMedGoogle Scholar
• Carré N, Caüzac M, Girard J, Burnol A-F. 2008. Dual effect of the adapter Grb14 on insulin action in primary hepatocytes. Endocrinology 149:3109–3117. http://dx.doi.org/10.1210/en.2007-1196.
   PubMedGoogle Scholar
• Goenaga D, Hampe C, Carre N, Cailliau K, Browaeys-Poly E, Perdereau D, Holt LJ, Daly RJ, Girard J, Broutin I, Issad T, Burnol AF. 2009. Molecular determinants of Grb14-mediated inhibition of insulin signaling. Mol Endocrinol 23:1043–1051. http://dx.doi.org/10.1210/me.2008-0360.
   PubMedGoogle Scholar
• Cariou B, Perdereau D, Cailliau K, Browaeys-Poly E, Béréziat V, Vasseur-Cognet M, Girard J, Burnol A-F. 2002. The adapter protein ZIP binds Grb14 and regulates its inhibitory action on insulin signaling by recruiting protein kinase Cz. Mol Cell Biol 22:6959–6970. http://dx.doi.org/10.1128/MCB.22.20.6959-6970.2002.
   PubMed Web of Science ®Google Scholar
• Moscat J, Diaz-Meco MT. 2012. p62: a versatile multitasker takes on cancer. Trends Biochem Sci 37:230–236. http://dx.doi.org/10.1016/j.tibs.2012.02.008.
   PubMed Web of Science ®Google Scholar
• Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, Nabeshima Y. 1997. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236:313–322. http://dx.doi.org/10.1006/bbrc.1997.6943.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang S, Blander G, Tse JG, Krieger M, Guarente L. 2007. SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell 28:91–106. http://dx.doi.org/10.1016/j.molcel.2007.07.032.
   PubMed Web of Science ®Google Scholar
• Dentin R, Benhamed F, Hainault I, Fauveau V, Foufelle F, Dyck JR, Girard J, Postic C. 2006. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 55:2159–2170. http://dx.doi.org/10.2337/db06-0200.
   PubMed Web of Science ®Google Scholar
• Ichimura Y, Waguri S, Sou YS, Kageyama S, Hasegawa J, Ishimura R, Saito T, Yang Y, Kouno T, Fukutomi T, Hoshii T, Hirao A, Takagi K, Mizushima T, Motohashi H, Lee MS, Yoshimori T, Tanaka K, Yamamoto M, Komatsu M. 2013. Phosphorylation of p62 activates the Keap1-Nrf2 pathway during selective autophagy. Mol Cell 51:618–631. http://dx.doi.org/10.1016/j.molcel.2013.08.003.
   PubMed Web of Science ®Google Scholar
• Wang XJ, Hayes JD, Wolf CR. 2006. Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents. Cancer Res 66:10983–10994. http://dx.doi.org/10.1158/0008-5472.CAN-06-2298.
   PubMed Web of Science ®Google Scholar
• Stansbie D, Brownsey RW, Crettaz M, Denton RM. 1976. Acute effects in vivo of anti-insulin serum on rates of fatty acid synthesis and activities of acetyl-coenzyme A carboxylase and pyruvate dehydrogenase in liver and epididymal adipose tissue of fed rats. Biochem J 160:413–416. http://dx.doi.org/10.1042/bj1600413.
   PubMed Web of Science ®Google Scholar
• Bobard A, Hainault I, Ferre P, Foufelle F, Bossard P. 2005. Differential regulation of sterol regulatory element-binding protein 1c transcriptional activity by insulin and liver X receptor during liver development. J Biol Chem 280:199–206. http://dx.doi.org/10.1074/jbc.M406522200.
   PubMedGoogle Scholar
• Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545–15550. http://dx.doi.org/10.1073/pnas.0506580102.
   PubMed Web of Science ®Google Scholar
• Ducheix S, Podechard N, Lasserre F, Polizzi A, Pommier A, Murzilli S, Di Lisio C, D'Amore S, Bertrand-Michel J, Montagner A, Pineau T, Loiseau N, Lobaccaro JM, Martin PG, Guillou H. 2013. A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARalpha. Biochimie 95:556–567. http://dx.doi.org/10.1016/j.biochi.2012.09.028.
   PubMedGoogle Scholar
• Yates MS, Tran QT, Dolan PM, Osburn WO, Shin S, McCulloch CC, Silkworth JB, Taguchi K, Yamamoto M, Williams CR, Liby KT, Sporn MB, Sutter TR, Kensler TW. 2009. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis 30:1024–1031. http://dx.doi.org/10.1093/carcin/bgp100.
   PubMed Web of Science ®Google Scholar
• Hegarty BD, Bobard A, Hainault I, Ferre P, Bossard P, Foufelle F. 2005. Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c. Proc Natl Acad Sci U S A 102:791–796. http://dx.doi.org/10.1073/pnas.0405067102.
   PubMedGoogle Scholar
• Goldstein JL, DeBose-Boyd RA, Brown MS. 2006. Protein sensors for membrane sterols. Cell 124:35–46. http://dx.doi.org/10.1016/j.cell.2005.12.022.
   PubMed Web of Science ®Google Scholar
• Chen G, Liang G, Ou J, Goldstein JL, Brown MS. 2004. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci U S A 101:11245–11250. http://dx.doi.org/10.1073/pnas.0404297101.
   PubMed Web of Science ®Google Scholar
• Kay HY, Kim WD, Hwang SJ, Choi HS, Gilroy RK, Wan YJ, Kim SG. 2011. Nrf2 inhibits LXRalpha-dependent hepatic lipogenesis by competing with FXR for acetylase binding. Antioxid Redox Signal 15:2135–2146. http://dx.doi.org/10.1089/ars.2010.3834.
   PubMed Web of Science ®Google Scholar
• Steffensen KR, Jakobsson T, Gustafsson JA. 2013. Targeting liver X receptors in inflammation. Expert Opin Ther Targets 17:977–990. http://dx.doi.org/10.1517/14728222.2013.806490.
   PubMed Web of Science ®Google Scholar
• Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, Kim M, Nishito Y, Iemura S, Natsume T, Ueno T, Kominami E, Motohashi H, Tanaka K, Yamamoto M. 2010. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 12:213–223. http://dx.doi.org/10.1038/ncb2021.
   PubMed Web of Science ®Google Scholar
• Bryan HK, Olayanju A, Goldring CE, Park BK. 2013. The Nrf2 cell defence pathway: Keap1-dependent and -independent mechanisms of regulation. Biochem Pharmacol 85:705–717. http://dx.doi.org/10.1016/j.bcp.2012.11.016.
   PubMed Web of Science ®Google Scholar
• Komatsu M. 2012. Liver autophagy: physiology and pathology. J Biochem 152:5–15. http://dx.doi.org/10.1093/jb/mvs059.
   PubMed Web of Science ®Google Scholar
• Rabinowitz JD, White E. 2010. Autophagy and metabolism. Science 330:1344–1348. http://dx.doi.org/10.1126/science.1193497.
   PubMed Web of Science ®Google Scholar
• Depetris RS, Hu J, Gimpelevich I, Holt LJ, Daly RJ, Hubbard SR. 2005. Structural basis for inhibition of the insulin receptor by the adaptor protein Grb14. Mol Cell 20:325–333. http://dx.doi.org/10.1016/j.molcel.2005.09.001.
   PubMedGoogle Scholar
• Cooney GJ, Lyons RJ, Crew AJ, Jensen TE, Molero JC, Mitchell CJ, Biden TJ, Ormandy CJ, James DE, Daly RJ. 2004. Improved glucose homeostasis and enhanced insulin signalling in Grb14-deficient mice. EMBO J 23:582–593. http://dx.doi.org/10.1038/sj.emboj.7600082.
   PubMed Web of Science ®Google Scholar
• Calkin AC, Tontonoz P. 2012. Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat Rev Mol Cell Biol 13:213–224. http://dx.doi.org/10.1038/nrm3312.
   PubMed Web of Science ®Google Scholar
• Jakobsson T, Treuter E, Gustafsson JA, Steffensen KR. 2012. Liver X receptor biology and pharmacology: new pathways, challenges and opportunities. Trends Pharmacol Sci 33:394–404. http://dx.doi.org/10.1016/j.tips.2012.03.013.
   PubMed Web of Science ®Google Scholar
• Hong C, Tontonoz P. 2014. Liver X receptors in lipid metabolism: opportunities for drug discovery. Nat Rev Drug Discov 13:433–444. http://dx.doi.org/10.1038/nrd4280.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Breevoort SR, Angdisen J, Fu M, Schmidt DR, Holmstrom SR, Kliewer SA, Mangelsdorf DJ, Schulman IG. 2012. Liver LXRalpha expression is crucial for whole body cholesterol homeostasis and reverse cholesterol transport in mice. J Clin Invest 122:1688–1699. http://dx.doi.org/10.1172/JCI59817.
   PubMed Web of Science ®Google Scholar
• Baird L, Dinkova-Kostova AT. 2011. The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol 85:241–272. http://dx.doi.org/10.1007/s00204-011-0674-5.
   PubMed Web of Science ®Google Scholar
• Kitteringham NR, Abdullah A, Walsh J, Randle L, Jenkins RE, Sison R, Goldring CE, Powell H, Sanderson C, Williams S, Higgins L, Yamamoto M, Hayes J, Park BK. 2010. Proteomic analysis of Nrf2 deficient transgenic mice reveals cellular defence and lipid metabolism as primary Nrf2-dependent pathways in the liver. J Proteomics 73:1612–1631. http://dx.doi.org/10.1016/j.jprot.2010.03.018.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Aleksunes LM, Yeager RL, Gyamfi MA, Esterly N, Guo GL, Klaassen CD. 2008. NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. J Pharmacol Exp Ther 325:655–664. http://dx.doi.org/10.1124/jpet.107.135822.
   PubMed Web of Science ®Google Scholar
• Hwahng SH, Ki SH, Bae EJ, Kim HE, Kim SG. 2009. Role of adenosine monophosphate-activated protein kinase-p70 ribosomal S6 kinase-1 pathway in repression of liver X receptor-alpha-dependent lipogenic gene induction and hepatic steatosis by a novel class of dithiolethiones. Hepatology 49:1913–1925. http://dx.doi.org/10.1002/hep.22887.
   PubMed Web of Science ®Google Scholar
• Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, Moore DD, Auwerx J. 2004. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest 113:1408–1418. http://dx.doi.org/10.1172/JCI21025.
   PubMed Web of Science ®Google Scholar
• Uruno A, Furusawa Y, Yagishita Y, Fukutomi T, Muramatsu H, Negishi T, Sugawara A, Kensler TW, Yamamoto M. 2013. The Keap1-Nrf2 system prevents onset of diabetes mellitus. Mol Cell Biol 33:2996–3010. http://dx.doi.org/10.1128/MCB.00225-13.
   PubMed Web of Science ®Google Scholar
• Mitsuishi Y, Taguchi K, Kawatani Y, Shibata T, Nukiwa T, Aburatani H, Yamamoto M, Motohashi H. 2012. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell 22:66–79. http://dx.doi.org/10.1016/j.ccr.2012.05.016.
   PubMed Web of Science ®Google Scholar
• Jain A, Lamark T, Sjottem E, Larsen KB, Awuh JA, Overvatn A, McMahon M, Hayes JD, Johansen T. 2010. p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 285:22576–22591. http://dx.doi.org/10.1074/jbc.M110.118976.
   PubMed Web of Science ®Google Scholar
• Duran A, Amanchy R, Linares JF, Joshi J, Abu-Baker S, Porollo A, Hansen M, Moscat J, Diaz-Meco MT. 2011. p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol Cell 44:134–146. http://dx.doi.org/10.1016/j.molcel.2011.06.038.
   PubMed Web of Science ®Google Scholar
• Li S, Brown MS, Goldstein JL. 2010. Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc Natl Acad Sci U S A 107:3441–3446. http://dx.doi.org/10.1073/pnas.0914798107.
   PubMed Web of Science ®Google Scholar
• Yecies JL, Zhang HH, Menon S, Liu S, Yecies D, Lipovsky AI, Gorgun C, Kwiatkowski DJ, Hotamisligil GS, Lee CH, Manning BD. 2011. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab 14:21–32. http://dx.doi.org/10.1016/j.cmet.2011.06.002.
   PubMed Web of Science ®Google Scholar
• Loh K, Deng H, Fukushima A, Cai X, Boivin B, Galic S, Bruce C, Shields BJ, Skiba B, Ooms LM, Stepto N, Wu B, Mitchell CA, Tonks NK, Watt MJ, Febbraio MA, Crack PJ, Andrikopoulos S, Tiganis T. 2009. Reactive oxygen species enhance insulin sensitivity. Cell Metab 10:260–272. http://dx.doi.org/10.1016/j.cmet.2009.08.009.
   PubMed Web of Science ®Google Scholar
• Tiganis T. 2011. Reactive oxygen species and insulin resistance: the good, the bad and the ugly. Trends Pharmacol Sci 32:82–89. http://dx.doi.org/10.1016/j.tips.2010.11.006.
   PubMed Web of Science ®Google Scholar
• Hardwick RN, Fisher CD, Canet MJ, Lake AD, Cherrington NJ. 2010. Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease. Drug Metab Dispos 38:2293–2301. http://dx.doi.org/10.1124/dmd.110.035006.
   PubMed Web of Science ®Google Scholar
• Chowdhry S, Nazmy MH, Meakin PJ, Dinkova-Kostova AT, Walsh SV, Tsujita T, Dillon JF, Ashford ML, Hayes JD. 2010. Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radic Biol Med 48:357–371. http://dx.doi.org/10.1016/j.freeradbiomed.2009.11.007.
   PubMed Web of Science ®Google Scholar
• Meakin PJ, Chowdhry S, Sharma RS, Ashford FB, Walsh SV, McCrimmon RJ, Dinkova-Kostova AT, Dillon JF, Hayes JD, Ashford ML. 2014. Susceptibility of Nrf2-null mice to steatohepatitis and cirrhosis upon consumption of a high-fat diet is associated with oxidative stress, perturbation of the unfolded protein response, and disturbance in the expression of metabolic enzymes but not with insulin resistance. Mol Cell Biol 34:3305–3320. http://dx.doi.org/10.1128/MCB.00677-14.
   PubMed Web of Science ®Google Scholar
• Uruno A, Yagishita Y, Yamamoto M. 2015. The Keap1-Nrf2 system and diabetes mellitus. Arch Biochem Biophys 566:76–84. http://dx.doi.org/10.1016/j.abb.2014.12.012.
   PubMed Web of Science ®Google Scholar